Dr David Busse, MD | |
221 W Colorado Blvd Ste 525, Dallas, TX 75208 | |
(214) 960-5681 | |
Not Available |
Full Name | Dr David Busse |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 6 Years |
Location | 221 W Colorado Blvd Ste 525, Dallas, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144727967 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0200X | Internal Medicine - Critical Care Medicine | S3643 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Medical City Dallas Hospital | Dallas, TX | Hospital |
Medical City Plano | Plano, TX | Hospital |
Baylor University Medical Center | Dallas, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dallas Pulmonary And Critical Care, Pa | 2163679200 | 145 |
Century Integrated Partners, Inc | 6406151703 | 232 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that for the first quarter ended March 31, 2015, adjusted net income was $141 million, compared to $122 million in 2014. Adjusted diluted EPS excluding amortization was $1.05 in the quarter, compared to $0.93 in 2014. Amortization expense was $0.09 per diluted share in both years.
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
"Women who had up to two drinks a day scored about 20 percent higher on the Mini Mental State Exam (MMSE) than women who didn't drink at all or who consumed less than one drink a week," said Clinton Wright, M.D., M.S., lead author of the study.
In a collaborative study published in Blood Advances, a research group led by Beate Heissig at Juntendo University and Yousef Salama at An Najah University report a strategy to overcome drug resistance developed by blood cancer cells.
Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) announced that health authorities are reviewing scientific data from two clinical trials evaluating an investigational use of the company's Alzheimer's treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment.
› Verified 5 days ago
Entity Name | University Of Texas Southwestern Medical Center At Dallas |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that for the first quarter ended March 31, 2015, adjusted net income was $141 million, compared to $122 million in 2014. Adjusted diluted EPS excluding amortization was $1.05 in the quarter, compared to $0.93 in 2014. Amortization expense was $0.09 per diluted share in both years.
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
"Women who had up to two drinks a day scored about 20 percent higher on the Mini Mental State Exam (MMSE) than women who didn't drink at all or who consumed less than one drink a week," said Clinton Wright, M.D., M.S., lead author of the study.
In a collaborative study published in Blood Advances, a research group led by Beate Heissig at Juntendo University and Yousef Salama at An Najah University report a strategy to overcome drug resistance developed by blood cancer cells.
Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) announced that health authorities are reviewing scientific data from two clinical trials evaluating an investigational use of the company's Alzheimer's treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment.
› Verified 5 days ago
Entity Name | Citydoc Urgent Care Center 2, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003044942 PECOS PAC ID: 9638354103 Enrollment ID: O20110427000050 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that for the first quarter ended March 31, 2015, adjusted net income was $141 million, compared to $122 million in 2014. Adjusted diluted EPS excluding amortization was $1.05 in the quarter, compared to $0.93 in 2014. Amortization expense was $0.09 per diluted share in both years.
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
"Women who had up to two drinks a day scored about 20 percent higher on the Mini Mental State Exam (MMSE) than women who didn't drink at all or who consumed less than one drink a week," said Clinton Wright, M.D., M.S., lead author of the study.
In a collaborative study published in Blood Advances, a research group led by Beate Heissig at Juntendo University and Yousef Salama at An Najah University report a strategy to overcome drug resistance developed by blood cancer cells.
Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) announced that health authorities are reviewing scientific data from two clinical trials evaluating an investigational use of the company's Alzheimer's treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment.
› Verified 5 days ago
Entity Name | Dallas Pulmonary & Critical Care, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235402728 PECOS PAC ID: 2163679200 Enrollment ID: O20120824000752 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that for the first quarter ended March 31, 2015, adjusted net income was $141 million, compared to $122 million in 2014. Adjusted diluted EPS excluding amortization was $1.05 in the quarter, compared to $0.93 in 2014. Amortization expense was $0.09 per diluted share in both years.
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
"Women who had up to two drinks a day scored about 20 percent higher on the Mini Mental State Exam (MMSE) than women who didn't drink at all or who consumed less than one drink a week," said Clinton Wright, M.D., M.S., lead author of the study.
In a collaborative study published in Blood Advances, a research group led by Beate Heissig at Juntendo University and Yousef Salama at An Najah University report a strategy to overcome drug resistance developed by blood cancer cells.
Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) announced that health authorities are reviewing scientific data from two clinical trials evaluating an investigational use of the company's Alzheimer's treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment.
› Verified 5 days ago
Entity Name | Citydoc Urgent Care Center 3 ,pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619237401 PECOS PAC ID: 3072762475 Enrollment ID: O20120928000285 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that for the first quarter ended March 31, 2015, adjusted net income was $141 million, compared to $122 million in 2014. Adjusted diluted EPS excluding amortization was $1.05 in the quarter, compared to $0.93 in 2014. Amortization expense was $0.09 per diluted share in both years.
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
"Women who had up to two drinks a day scored about 20 percent higher on the Mini Mental State Exam (MMSE) than women who didn't drink at all or who consumed less than one drink a week," said Clinton Wright, M.D., M.S., lead author of the study.
In a collaborative study published in Blood Advances, a research group led by Beate Heissig at Juntendo University and Yousef Salama at An Najah University report a strategy to overcome drug resistance developed by blood cancer cells.
Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) announced that health authorities are reviewing scientific data from two clinical trials evaluating an investigational use of the company's Alzheimer's treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment.
› Verified 5 days ago
Entity Name | Century Integrated Partners, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447615711 PECOS PAC ID: 6406151703 Enrollment ID: O20160224002152 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that for the first quarter ended March 31, 2015, adjusted net income was $141 million, compared to $122 million in 2014. Adjusted diluted EPS excluding amortization was $1.05 in the quarter, compared to $0.93 in 2014. Amortization expense was $0.09 per diluted share in both years.
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
"Women who had up to two drinks a day scored about 20 percent higher on the Mini Mental State Exam (MMSE) than women who didn't drink at all or who consumed less than one drink a week," said Clinton Wright, M.D., M.S., lead author of the study.
In a collaborative study published in Blood Advances, a research group led by Beate Heissig at Juntendo University and Yousef Salama at An Najah University report a strategy to overcome drug resistance developed by blood cancer cells.
Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) announced that health authorities are reviewing scientific data from two clinical trials evaluating an investigational use of the company's Alzheimer's treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment.
› Verified 5 days ago
Entity Name | Cd Urgent Care Center 5, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407224850 PECOS PAC ID: 5698070928 Enrollment ID: O20160225000180 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that for the first quarter ended March 31, 2015, adjusted net income was $141 million, compared to $122 million in 2014. Adjusted diluted EPS excluding amortization was $1.05 in the quarter, compared to $0.93 in 2014. Amortization expense was $0.09 per diluted share in both years.
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
"Women who had up to two drinks a day scored about 20 percent higher on the Mini Mental State Exam (MMSE) than women who didn't drink at all or who consumed less than one drink a week," said Clinton Wright, M.D., M.S., lead author of the study.
In a collaborative study published in Blood Advances, a research group led by Beate Heissig at Juntendo University and Yousef Salama at An Najah University report a strategy to overcome drug resistance developed by blood cancer cells.
Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) announced that health authorities are reviewing scientific data from two clinical trials evaluating an investigational use of the company's Alzheimer's treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr David Busse, MD 221 W Colorado Blvd Ste 525, Dallas, TX 75208-2312 Ph: (214) 960-5681 | Dr David Busse, MD 221 W Colorado Blvd Ste 525, Dallas, TX 75208 Ph: (214) 960-5681 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that for the first quarter ended March 31, 2015, adjusted net income was $141 million, compared to $122 million in 2014. Adjusted diluted EPS excluding amortization was $1.05 in the quarter, compared to $0.93 in 2014. Amortization expense was $0.09 per diluted share in both years.
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
"Women who had up to two drinks a day scored about 20 percent higher on the Mini Mental State Exam (MMSE) than women who didn't drink at all or who consumed less than one drink a week," said Clinton Wright, M.D., M.S., lead author of the study.
In a collaborative study published in Blood Advances, a research group led by Beate Heissig at Juntendo University and Yousef Salama at An Najah University report a strategy to overcome drug resistance developed by blood cancer cells.
Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) announced that health authorities are reviewing scientific data from two clinical trials evaluating an investigational use of the company's Alzheimer's treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment.
› Verified 5 days ago
Uma B.r.k Pakkivenkata, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 215, Dallas, TX 75231 Phone: 214-396-4950 Fax: 877-423-5360 | |
Dr. Ariel Marcelo Modrykamien, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3600 Gaston Ave, Wadley Tower, Suite 960, Dallas, TX 75246 Phone: 402-972-6078 | |
Benjamin Seth Martinez, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3111 Fax: 214-648-5461 | |
Vijaya Mummadi, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 225, Dallas, TX 75231 Phone: 469-646-8880 Fax: 469-646-8884 | |
Dr. Ting-yi Chen, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2800 Fax: 214-645-2808 | |
William Cook Langmade, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1441 N Beckley Ave, Dallas, TX 75203 Phone: 214-947-2306 | |
Dr. Janame J Kottey, MBBS Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 13154 Coit Rd Ste 100, Dallas, TX 75240 Phone: 214-358-2300 Fax: 214-579-6989 |